RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS SCIE

      Chronic Kidney Disease and Associated Cardiovascular Risk Factors in Chinese with Type 2 Diabetes

      한글로보기

      https://www.riss.kr/link?id=A104750807

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Background: To determine the frequency of chronic kidney disease (CKD) and its associated risk factors in Chinese type 2 diabetic patients, we conducted a cross-sectional study in Nanjing, China, in the period between January 2008 and December 2009. M...

      Background: To determine the frequency of chronic kidney disease (CKD) and its associated risk factors in Chinese type 2 diabetic patients, we conducted a cross-sectional study in Nanjing, China, in the period between January 2008 and December 2009.
      Methods: Patients with type 2 diabetes under the care by Jiangsu Province Official Hospital, Nanjing, China were invited for assessment.
      CKD was defined as the presence of albuminuria or estimated glomerular filtration rate <60 mL/min/1.73 m2. Albuminuria was defined as urinary albumin-to-creatinine ratio ≥30 mg/g.
      Results: We recruited 1,521 urban Chinese patients with type 2 diabetes (mean age, 63.9±12.0 years). The frequency of CKD and albuminuria was 31.0% and 28.9%, respectively. After adjusted by age and sex, hypertension, anemia and duration of diabetes were significantly associated with CKD with odds ratio (95% confidence interval) being 1.93 (1.28 to 2.93), 1.70 (1.09 to 2.64), and 1.03 (1.00 to 1.06), respectively.
      Conclusion: In conclusion, CKD was common in the urban Nanjing Chinese with type 2 diabetes. Strategies to prevent or delay progression of kidney disease in diabetes should be carried out at the early disease course of type 2 diabetes.

      더보기

      참고문헌 (Reference)

      1 Xu R, "The prevalence and risk factors of kidney disease in type 2 diabetic patients in rural Shanghai" 51 : 18-23, 2012

      2 Mohanram A, "The effect of losartan on hemoglobin concentration and renal outcome in diabetic nephropathy of type 2 diabetes" 73 : 630-636, 2008

      3 American Diabetes Association, "Standards of medical care in diabetes: 2009" 32 (32): S13-S61, 2009

      4 Premaratne E, "Serial measurements of cystatin C are more accurate than creatinine-based methods in detecting declining renal function in type 1 diabetes" 31 : 971-973, 2008

      5 American Diabetes Assoication, "Report of the expert committee on the diagnosis and classification of diabetes mellitus" 20 : 1183-1197, 1997

      6 Mann JF, "Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial" 372 : 547-553, 2008

      7 Burrows NR, "Racial and ethnic differences in trends of end-stage renal disease: United States, 1995 to 2005" 15 : 147-152, 2008

      8 Yang W, "Prevalence of diabetes among men and women in China" 362 : 1090-1101, 2010

      9 Jia W, "Prevalence and risk factors of albuminuria and chronic kidney disease in Chinese population with type 2 diabetes and impaired glucose regulation: Shanghai diabetic complications study (SHDCS)" 24 : 3724-3731, 2009

      10 Dirren H, "Nutritional status: haematology and albumin. Euronut SENECA investigators" 45 (45): 43-52, 1991

      1 Xu R, "The prevalence and risk factors of kidney disease in type 2 diabetic patients in rural Shanghai" 51 : 18-23, 2012

      2 Mohanram A, "The effect of losartan on hemoglobin concentration and renal outcome in diabetic nephropathy of type 2 diabetes" 73 : 630-636, 2008

      3 American Diabetes Association, "Standards of medical care in diabetes: 2009" 32 (32): S13-S61, 2009

      4 Premaratne E, "Serial measurements of cystatin C are more accurate than creatinine-based methods in detecting declining renal function in type 1 diabetes" 31 : 971-973, 2008

      5 American Diabetes Assoication, "Report of the expert committee on the diagnosis and classification of diabetes mellitus" 20 : 1183-1197, 1997

      6 Mann JF, "Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial" 372 : 547-553, 2008

      7 Burrows NR, "Racial and ethnic differences in trends of end-stage renal disease: United States, 1995 to 2005" 15 : 147-152, 2008

      8 Yang W, "Prevalence of diabetes among men and women in China" 362 : 1090-1101, 2010

      9 Jia W, "Prevalence and risk factors of albuminuria and chronic kidney disease in Chinese population with type 2 diabetes and impaired glucose regulation: Shanghai diabetic complications study (SHDCS)" 24 : 3724-3731, 2009

      10 Dirren H, "Nutritional status: haematology and albumin. Euronut SENECA investigators" 45 (45): 43-52, 1991

      11 Levey AS, "National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification" 139 : 137-147, 2003

      12 Perkins BA, "Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes" 18 : 1353-1361, 2007

      13 Babazono T, "Lower haemoglobin level and subsequent decline in kidney function in type 2 diabetic adults without clinical albuminuria" 49 : 1387-1393, 2006

      14 KDOQI, "KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease" 49 (49): S12-S154, 2007

      15 ADVANCE Collaborative Group, "Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes" 358 : 2560-2572, 2008

      16 Lu B, "High prevalence of chronic kidney disease in population-based patients diagnosed with type 2 diabetes in downtown Shanghai" 22 : 96-103, 2008

      17 Rigalleau V, "Glucose control influences glomerular filtration rate and its prediction in diabetic subjects" 29 : 1491-1495, 2006

      18 Duckworth W, "Glucose control and vascular complications in veterans with type 2 diabetes" 360 : 129-139, 2009

      19 So WY, "Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients" 29 : 2046-2052, 2006

      20 Targher G, "Glomerular filtration rate, albuminuria and risk of cardiovascular and all-cause mortality in type 2 diabetic individuals" 21 : 294-301, 2011

      21 Ahmed AT, "Ethnic differences in anemia among patients with diabetes mellitus: the Diabetes Study of Northern California (DISTANCE)" 85 : 57-61, 2010

      22 Rigalleau V, "Estimation of glomerular filtration rate in diabetic subjects: Cockcroft formula or modification of Diet in Renal Disease study equation?" 28 : 838-843, 2005

      23 Bruno G, "Estimated glomerular filtration rate, albuminuria and mortality in type 2 diabetes: the Casale Monferrato study" 50 : 941-948, 2007

      24 Colhoun HM, "Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS)" 54 : 810-819, 2009

      25 Rigalleau V, "Cockcroft-Gault formula is biased by body weight in diabetic patients with renal impairment" 55 : 108-112, 2006

      26 Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults, "Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary" 68 : 899-917, 1998

      27 Poulsen PL, "Clinical evaluation of a test for immediate and quantitative determination of urinary albumin-tocreatinine ratio. A brief report" 21 : 97-98, 1998

      28 Iseki K, "Chronic kidney disease in Japan" 47 : 681-689, 2008

      29 Hsieh MC, "Chronic kidney disease as a risk factor for coronary artery disease in Chinese with type 2 diabetes" 28 : 317-323, 2008

      30 Joint Committee for Developing Chinese guidelines on Prevention and Treatment of Dyslipidemia in Adults, "Chinese guidelines on prevention and treatment of dyslipidemia in adults" 35 : 390-419, 2007

      31 Adler AI, "Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study" 321 : 412-419, 2000

      32 Stratton IM, "Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study" 321 : 405-412, 2000

      33 Kong AP, "Assessment of glomerular filtration rate in addition to albuminuria is important in managing type II diabetes" 69 : 383-387, 2006

      34 Mehdi U, "Anemia, diabetes, and chronic kidney disease" 32 : 1320-1326, 2009

      35 Sasatomi Y, "Anemia and hypertension are risk factors for both renal prognosis and survival in patients with diabetes mellitus" 13 : 473-479, 2009

      36 Hirsch AT, "ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation" 113 : e463-e654, 2006

      37 Levey AS, "A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group" 130 : 461-470, 1999

      38 Lin CH, "A communitybased study of chronic kidney disease among type 2 diabetics in Kinmen, Taiwan" 75 : 306-312, 2007

      39 World Health Organiz, "1999 World Health Organization- International Society of Hypertension Guidelines for the Management of Hypertension: guidelines subcommittee" 17 : 151-183, 1999

      40 Holman RR, "10- year follow-up of intensive glucose control in type 2 diabetes" 359 : 1577-1589, 2008

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2017-12-01 평가 SCIE 등재 (기타) KCI등재
      2011-05-30 학술지명변경 한글명 : KOREAN DIABETES JOURNAL -> Diabetes and Metabolism Journal KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2006-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2005-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2004-01-01 평가 등재후보학술지 유지 (등재후보1차) KCI등재후보
      2003-01-01 평가 등재후보학술지 유지 (등재후보1차) KCI등재후보
      2002-01-01 평가 등재후보학술지 유지 (등재후보1차) KCI등재후보
      2000-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.55 0.55 0.55
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.49 0.5 1.018 0.21
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼